Ryan Meyers's questions to LifeMD Inc (LFMD) leadership • Q2 2025
Question
Ryan Meyers of Lake Street Capital Markets sought confirmation that the full-year guidance reduction was primarily due to challenges in the RexMD business and asked about marketing spend for the new LifeMD Plus offering.
Answer
CFO Marc Benathen confirmed the vast majority of the guidance revision stemmed from RexMD's Q2 performance and its downstream impact, with a smaller portion from higher refund rates in weight management. He noted the new guidance is prudent and does not assume a full rebound. Regarding LifeMD Plus, he stated marketing spend is included in the plan and will be scaled in a measured way to balance growth and profitability.